-transparent.png){kind=logo}
Gingial hyperplasia is a complication which may be seen in a significant number of patients taking nifedipine (Procardia, Pfizer) a commonly used medication for cardiac vessel dilitation. This is a report of gingival changes in a 43-year-old hypertensive male who began using the calcium channel blocking agent during his active dental treatment. Gingival hyperplasia developed which was severe enough to alter the course of his dental treatment and prompt his changing to other medications to control his blood pressure. The recognition that the drug was responsible for the hyperplasia led to prompt and effective methods to resolve this problem.
Related Publications
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
January 1992,
Annals of dentistry,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
January 1986,
Drug intelligence & clinical pharmacy,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
March 1996,
American family physician,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
January 1991,
Revista europea de odonto-estomatologia,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
May 1989,
Journal (Canadian Dental Association),
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
December 1992,
Dental update,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
January 1988,
Duodecim; laaketieteellinen aikakauskirja,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
October 1987,
Medicina clinica,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
June 1991,
The Journal of the Association of Physicians of India,
E J Burkes, and
J R Jacoway, and
D T Stevens, and
M E Braddock
March 1988,
The Journal of the Association of Physicians of India,
